ClinVar Miner

Submissions for variant NM_000138.5(FBN1):c.1545_1546inv (p.Cys515_Arg516delinsTrpGly)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories RCV003120250 SCV003800287 pathogenic not provided 2022-04-21 criteria provided, single submitter clinical testing The FBN1 c.1545_1546delinsGG; p.Cys515_Arg516delinsTrpGly variant is reported in the literature to segregate with a clinical diagnosis of Marfan syndrome in a large family (Villamizar 2010). This variant is absent from the Genome Aggregation Database, indicating it is not a common polymorphism. This variant involves a cysteine residue in one of the calcium binding EGF-like domains of fibrillin-1 (Wu 1995). Each EGF-like domain contains six highly-conserved cysteines and the disulfide bridges formed between these residues are essential for protein folding; loss of one of these cysteines may interfere with proper disulfide bridge formation, disrupting protein structure. Accordingly, the revised Ghent nosology for Marfan syndrome lists loss of cysteine residues as one of the criteria for classification of a variant as pathogenic (Loeys 2010). Based on available information, this variant is considered to be pathogenic. References: Loeys BL et al. The revised Ghent nosology for the Marfan syndrome. J Med Genet. 2010 Jul;47(7):476-85. PMID: 20591885. Villamizar C et al. Paucity of skeletal manifestations in Hispanic families with FBN1 mutations. Eur J Med Genet. 2010 Mar-Apr;53(2):80-4. PMID: 19941982. Wu YS et al. Fibrillin domain folding and calcium binding: significance to Marfan syndrome. Chem Biol. 1995 Feb;2(2):91-7. PMID: 9383409.
GeneDx RCV003120250 SCV004021546 likely pathogenic not provided 2023-07-18 criteria provided, single submitter clinical testing Affects a cysteine residue within a calcium-binding EGF-like domain of the FBN1 gene, which may affect disulfide bonding and is predicted to alter the structure and function of the protein; cysteine substitutions in the calcium-binding EGF-like domains represent the majority of pathogenic missense changes associated with FBN1-related disorders (Collod-Beroud et al., 2003); Identified in a patient with ascending aortic dissection and ectopia lentis and was identified in 7 other family members with ocular and/or cardiovascular features of Marfan syndrome; however, skeletal features were not present in any members of this family (Villamizer et al., 2010); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 10486319, 12938084, 19941982)

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.